CanBas Co., Ltd. (TYO:4575)

Kronos Bio Income Statement

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	-	-	-	-	108
Revenue Growth (YoY)	-	-	-	-	-1.82%
Cost of Revenue	-	984	671	608	430
Gross Profit	-	-984	-671	-608	-322
Selling, General & Admin	289	191	184	175	174
Research & Development	820	-	-	-	-
Other Operating Expenses	-	87	110	63	52
Operating Expenses	1,109	278	294	238	226
Operating Income	-1,109	-1,262	-965	-846	-548
Interest Expense	-	-	-1	-5	-7
Interest & Investment Income	1	-	-	-	-
Currency Exchange Gain (Loss)	-42	59	4	-	3
Other Non Operating Income (Expenses)	-6	-5	-321	-3	-3
EBT Excluding Unusual Items	-1,156	-1,208	-1,283	-854	-555
Other Unusual Items	-	-	40	-	25
Pretax Income	-1,156	-1,208	-1,243	-854	-530
Income Tax Expense	1	1	1	1	1
Net Income	-1,157	-1,209	-1,244	-855	-531
Net Income to Common	-1,157	-1,209	-1,244	-855	-531
Shares Outstanding (Basic)	19	18	15	10	8
Shares Outstanding (Diluted)	19	18	15	10	8
Shares Change (YoY)	6.31%	18.89%	54.67%	27.73%	10.75%
EPS (Basic)	-61.09	-67.87	-83.03	-88.26	-70.01
EPS (Diluted)	-61.09	-67.87	-83.03	-88.26	-70.01
Free Cash Flow	-	-1,280	-1,398	-719	-688
Free Cash Flow Per Share	-	-71.85	-93.30	-74.22	-90.72
Gross Margin	-	-	-	-	-298.15%
Operating Margin	-	-	-	-	-507.41%
Profit Margin	-	-	-	-	-491.67%
Free Cash Flow Margin	-	-	-	-	-637.04%
EBIT	-1,109	-1,262	-965	-846	-548

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.